DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Last week, the President’s Emergency Plan for AIDS Relief narrowly avoided a $400 million budget cut, thanks to bipartisan support. However, preserving PEPFAR should not be the ultimate goal; global ...

Health Could This Shot Prevent HIV? Lenacapavir prevents HIV when given every 6 months—here’s what you need to know. Posted July 8, 2025 | Reviewed by Kaja Perina ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 clinical trial has shown.

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries. Manufactured by US ...

HIV advocates hope lenacapavir, a long-acting, injectable HIV-prevention drug, could be a game changer in the fight against the virus. Nardus Engelbrecht / AP file Sept. 12, 2024, 9:43 AM EDT ...

A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23 ...